Stock Events

Stock Events

Cns Pharmaceuticals (CNSP) Q1 2026 Earnings

31MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-24

-17.7

-11.39

-5.09

Details

Expected EPS

-5.09

Actual EPS

-5.09

Surprise EPS

0

Surprise Percent

+0%

Description

Cns Pharmaceuticals (CNSP) has reported earnings of -5.09 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.